Advocacy Group Seeks Ban on Cadaver Brain Tissue Use
WASHINGTON, DC-The Public Citizen Health Research Group is asking officials from the Food and Drug Administration to prevent physicians from using cadaver brain tissue in surgeries. They argue this practice is responsible for transmitting the genetic form of Creutzfeldt-Jakob disease (CJD).
Reportedly more than 114 people have died from CJD after having brain surgery that included the transplantation of some cadaver brain tissue. Infected tissue can spread the disease, which causes proteins to reproduce into misshapen, folded cells, known as prions.
Public Citizen says there are other options available to physicians. The FDA recommended that neurologists avoid using human dura matter in 1999. They also created a list of rules to follow when preparing such tissue for surgery. The World Health Organization has also strongly recommended against the practice.
Information from www.nytimes.com
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
